Financial Highlights Operating revenues were $29.3 million for the nine months ended September 30, 2018, a 48% increase, as compared to $19.8 million for the same period the prior year. For the three months ended September 30, 2018, the gross profit margin increased to 9.3% from 8.1% for the same period in 2017. For the nine months ...

Financial Highlights for the three months ended June 30, 2018: Revenues were $8.8 million, a 45% increase, as compared to $6.1 million for the same period the prior year. Gross profit was $702 thousand, a 46% increase, as compared to $480 thousand for the same period the prior year. ...

Highlights: Quarter ended March 31, 2018, versus the quarter ended March 31, 2017, revenue improved 191% to $11.9 million from $4.1 million. Gross profit increased 67.7% to $609,996 in the first quarter of 2017 from $363,692 in the first quarter of 2016. Debt refinancing in the amount of $3,199,728 from interest rate of ten (10%) percent per annum was adjusted to ...

Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., offers a first look at its Sky Life Premium® Brand of food supplements. CHICAGO, IL- - April 19, 2018 - Cosmos Holdings, Inc. (OTCQB: COSM), released the design and packaging of its first set of dietary supplements. These premium supplements boast a sleek design and packaging along with best in class formulation. The first lines of products include: A herbal ...

CHICAGO, April 20, 2018 - Cosmos Holdings, Inc. (Cosmos) (COSM), an international pharmaceutical company, announced today its full-year 2017 financial results for the year ended December 31, 2017. Full-year 2017 revenue increased 347% to $30.0 million from $6.7 million in 2016, fueled by strong execution on customer network expansion and by securing approximately $10.2 million in additional capital. Cosmos also achieved gross profit growth of 225% in 2017, an increase to $1.95 million in 2017 from ...